What is Kaiima?
Kaiima operates at the intersection of advanced genetics and large-scale agricultural production. By focusing on the development of high-yield hybrid castor seeds, the company provides essential solutions for the vegetable oil industry and its diverse derivatives. Its core platform integrates sophisticated genetic improvement techniques with modern agronomic management, enabling sustainable, high-efficiency crop production. Beyond seed technology, Kaiima is actively involved in the broader agricultural value chain, offering innovative fertilizers and raw material solutions that cater to the evolving demands of global industrial agriculture. The company's commitment to sustainability and technological precision positions it as a critical player in the modernization of industrial crop systems.
How much funding has Kaiima raised?
Kaiima has raised a total of $83M across 2 funding rounds:
Unspecified
$18M
Unspecified
$65M
Unspecified (2011): $18M with participation from Kleiner Perkins Caufield & Byers, DFJ Tamir Fishman Ventures, and Draper Fisher Jurvetson
Unspecified (2013): $65M led by Horizons Ventures, International Financial Corp., Kleiner Perkins Caufield & Byers, Infinity Group, Musea Ventures, and Draper Fisher Jurvetson
Key Investors in Kaiima
Kleiner Perkins Caufield & Byers
A Menlo Park-based venture capital firm that invests in early and growth-stage technology and life science companies, providing operational support from seed through IPO.
Draper Fisher Jurvetson
A global venture capital firm with a mission to identify and provide capital for extraordinary entrepreneurs determined to change the world across multiple sectors.
International Financial Corp.
A multilateral financial institution dedicated to mobilizing capital and expertise for sustainable development and private sector growth across emerging markets.
What's next for Kaiima?
With the recent influx of capital, Kaiima is well-positioned to accelerate its commercial expansion and deepen its research and development capabilities. The strategic focus will likely shift toward optimizing the supply chain for castor oil derivatives and expanding the footprint of its hybrid seed platform into new geographic markets. As the company transitions from a development-heavy phase to a mature commercial entity, the emphasis will remain on scaling production capacity to meet the rising global demand for sustainable, bio-based industrial inputs. Future growth will be driven by the continued refinement of its genetic platform and the strengthening of partnerships across the agricultural and chemical sectors.
See full Kaiima company page
